Trial Profile
MicroRNA Expression in Everolimus-based Versus Tacrolimus-based Maintenance Immunosuppressive Regimens in Kidney Transplantation
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Biomarker; Pharmacodynamics
- 16 May 2014 New trial record